scholarly journals Predictors of Basal Cell Carcinoma in High-Risk Patients in the VATTC (VA Topical Tretinoin Chemoprevention) Trial

2012 ◽  
Vol 132 (11) ◽  
pp. 2544-2551 ◽  
Author(s):  
Robert K. Dyer ◽  
Martin A. Weinstock ◽  
Tobias S.D. Cohen ◽  
Amilcar E. Rizzo ◽  
Stephen F. Bingham ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Topical Tretinoin ◽  
High Risk Patients ◽  
Risk Patients ◽  
Chemoprevention Trial

scholarly journals 275 Predictors of basal cell carcinoma and implications for follow up in high-risk patients in the VAKCC Trial

2019 ◽  
Vol 139 (5) ◽  
pp. S47
Author(s):  
M. Beatson ◽  
A. Misitzis ◽  
S. Landow ◽  
H. Higgins ◽  
R. Lew ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
High Risk Patients ◽  
Risk Patients

995: Immunohistochemical Analysis of Tumor Polyamines Discriminates High Risk Patients Undergoing Nephrectomy for Renal Cell Carcinoma

2004 ◽  
Vol 171 (4S) ◽  
pp. 263-263
Author(s):  
Nathalie Rioux-Leclercq ◽  
Florence Jouan ◽  
Pascale Bellaud ◽  
Jacques-Philippe Moulinoux ◽  
Karim Bensalah ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
High Risk ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Immunohistochemical Analysis ◽  
High Risk Patients ◽  
Risk Patients

The combined effect of CO 2 laser, topical diclofenac 3%, and imiquimod 5% in treating high‐risk basal cell carcinoma

2021 ◽  
Author(s):  
Mohamed El‐Khalawany ◽  
Wael M. Saudi ◽  
Eman Ahmed ◽  
Alsadat Mosbeh ◽  
Ahmed Sameh ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Combined Effect ◽  
Topical Diclofenac
Sign in / Sign up

Export Citation Format

Share Document